{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T09:42:31Z","timestamp":1777110151920,"version":"3.51.4"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,2,15]],"date-time":"2017-02-15T00:00:00Z","timestamp":1487116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,2,15]],"date-time":"2017-02-15T00:00:00Z","timestamp":1487116800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>A family history of cutaneous melanoma (\u2018melanoma\u2019) is a well-established risk factor for melanoma. However, less is known about the possible familial associations of melanoma with other discordant cancers. A risk for discordant cancer may provide useful information about shared genetic and environmental risk factors and it may be relevant background data in clinical genetic counseling. Using the Swedish Family-Cancer Database, we assessed the relative risk (RR) for any cancer in families with increasing numbers of first-degree relatives diagnosed with melanoma, including multiple melanoma, and in reverse order RR for melanoma in families of multiple discordant cancers. Close to 9% of melanoma was familial; among these 92% were in 2-case families and 8% in families with 3 cases or more. Cancers that were associated with melanoma, in at least two independent analyses, included breast, prostate, colorectal, skin and nervous system cancers. Other associations included cancer of unknown primary, acute myeloid leukemia\/myelofibrosis and Waldenstr\u00f6m macroglobulinemia\/myeloma. Significant results, which appear biologically plausible, were also obtained for rare nasal melanoma and mesothelioma. Although small samples sizes and multiple comparisons were of concern, many of the above associations were internally consistent and provide new diverse leads for discordant familial association of melanoma.<\/jats:p>","DOI":"10.1038\/srep42601","type":"journal-article","created":{"date-parts":[[2017,2,15]],"date-time":"2017-02-15T10:21:44Z","timestamp":1487154104000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Risk of other Cancers in Families with Melanoma: Novel Familial Links"],"prefix":"10.1038","volume":"7","author":[{"given":"Christoph","family":"Frank","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Sundquist","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akseli","family":"Hemminki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kari","family":"Hemminki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,2,15]]},"reference":[{"key":"BFsrep42601_CR1","doi-asserted-by":"publisher","first-page":"12891","DOI":"10.1038\/srep12891","volume":"5","author":"C Frank","year":"2015","unstructured":"Frank, C., Fallah, M., Sundquist, J., Hemminki, A. & Hemminki, K. Population Landscape of Familial Cancer. Sci Rep 5, 12891 (2015).","journal-title":"Sci Rep"},{"key":"BFsrep42601_CR2","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1016\/j.ejca.2011.09.017","volume":"48","author":"K Hemminki","year":"2012","unstructured":"Hemminki, K., Sundquist, J. & Brandt, A. Do discordant cancers share familial susceptibility? Eur J Cancer 48, 1200\u20137 (2012).","journal-title":"Eur J Cancer"},{"key":"BFsrep42601_CR3","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/gim.2011.2","volume":"14","author":"CC Teerlink","year":"2012","unstructured":"Teerlink, C. C., Albright, F. S., Lins, L. & Cannon-Albright, L. A. A comprehensive survey of cancer risks in extended families. Genetics in Medicine 14, 107\u2013114 (2012).","journal-title":"Genetics in Medicine"},{"key":"BFsrep42601_CR4","doi-asserted-by":"publisher","first-page":"2659","DOI":"10.1016\/j.ejca.2014.07.007","volume":"50","author":"T Chen","year":"2014","unstructured":"Chen, T. et al. Multiple primary (even in situ) melanomas in a patient pose significant risk to family members. Eur J Cancer 50, 2659\u201367 (2014).","journal-title":"Eur J Cancer"},{"key":"BFsrep42601_CR5","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1038\/jid.2013.460","volume":"134","author":"T Chen","year":"2014","unstructured":"Chen, T. et al. Effect of a detailed family history of melanoma on risk for other tumors: a cohort study based on the nationwide Swedish Family-Cancer Database. J Invest Dermatol 134, 930\u20136 (2014).","journal-title":"J Invest Dermatol"},{"key":"BFsrep42601_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/jmedgenet-2015-103150","volume":"53","author":"J Read","year":"2016","unstructured":"Read, J., Wadt, K. A. & Hayward, N. K. Melanoma genetics. J Med Genet 53, 1\u201314 (2016).","journal-title":"J Med Genet"},{"key":"BFsrep42601_CR7","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/nrc3459","volume":"13","author":"M Carbone","year":"2013","unstructured":"Carbone, M. et al. BAP1 and cancer. Nat Rev Cancer 13, 153\u20139 (2013).","journal-title":"Nat Rev Cancer"},{"key":"BFsrep42601_CR8","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1136\/jclinpath-2016-203866","volume":"69","author":"A Wang","year":"2016","unstructured":"Wang, A., Papneja, A., Hyrcza, M., Al-Habeeb, A. & Ghazarian, D. BAP1: gene of the month. J Clin Pathol 69, 750\u20133 (2016).","journal-title":"J Clin Pathol"},{"key":"BFsrep42601_CR9","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1002\/ijc.10332","volume":"99","author":"K Czene","year":"2002","unstructured":"Czene, K., Lichtenstein, P. & Hemminki, K. Environmental and heritable causes of cancer among 9.6 million individuals in the Swedish Family-Cancer Database. Int J Cancer 99, 260\u20136 (2002).","journal-title":"Int J Cancer"},{"key":"BFsrep42601_CR10","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1002\/ijc.28510","volume":"134","author":"C Frank","year":"2014","unstructured":"Frank, C., Fallah, M., Ji, J., Sundquist, J. & Hemminki, K. The population impact of familial cancer, a major cause of cancer. Int J Cancer 134, 1899\u2013906 (2014).","journal-title":"Int J Cancer"},{"key":"BFsrep42601_CR11","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1136\/jmg.2006.043802","volume":"44","author":"AM Goldstein","year":"2007","unstructured":"Goldstein, A. M. et al. Features associated with germline CDKN2A mutations: a GenoMEL study of melanoma-prone families from three continents. J Med Genet 44, 99\u2013106 (2007).","journal-title":"J Med Genet"},{"key":"BFsrep42601_CR12","doi-asserted-by":"crossref","unstructured":"Helgadottir, H. et al. Germline CDKN2A Mutation Status and Survival in Familial Melanoma Cases. J Natl Cancer Inst 108 (2016).","DOI":"10.1093\/jnci\/djw135"},{"key":"BFsrep42601_CR13","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1038\/ng.3373","volume":"47","author":"MH Law","year":"2015","unstructured":"Law, M. H. et al. Genome-wide meta-analysis identifies five new susceptibility loci for cutaneous malignant melanoma. Nat Genet 47, 987\u201395 (2015).","journal-title":"Nat Genet"},{"key":"BFsrep42601_CR14","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1038\/leu.2015.279","volume":"30","author":"C Frank","year":"2016","unstructured":"Frank, C. et al. Search for familial clustering of multiple myeloma with any cancer Leukemia 30, 627\u201332 (2016).","journal-title":"Leukemia"},{"key":"BFsrep42601_CR15","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1097\/MOH.0000000000000017","volume":"21","author":"R Rampal","year":"2014","unstructured":"Rampal, R. & Mascarenhas, J. Pathogenesis and management of acute myeloid leukemia that has evolved from a myeloproliferative neoplasm. Curr Opin Hematol 21, 65\u201371 (2014).","journal-title":"Curr Opin Hematol"},{"key":"BFsrep42601_CR16","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1016\/S0140-6736(11)61178-1","volume":"379","author":"N Pavlidis","year":"2012","unstructured":"Pavlidis, N. & Pentheroudakis, G. Cancer of unknown primary site. Lancet 379, 1428\u201335 (2012).","journal-title":"Lancet"},{"key":"BFsrep42601_CR17","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1200\/JCO.2010.31.5614","volume":"29","author":"K Hemminki","year":"2011","unstructured":"Hemminki, K., Ji, J., Sundquist, J. & Shu, X. Familial risks in cancer of unknown primary: tracking the primary sites. J Clin Oncol 29, 435\u201340 (2011).","journal-title":"J Clin Oncol"},{"key":"BFsrep42601_CR18","doi-asserted-by":"publisher","first-page":"22891","DOI":"10.1038\/srep22891","volume":"6","author":"K Hemminki","year":"2016","unstructured":"Hemminki, K., Sundquist, K., Sundquist, J., Hemminki, A. & Ji, J. Location of metastases in cancer of unknown primary are not random and signal familial clustering. Sci Rep 6, 22891 (2016).","journal-title":"Sci Rep"},{"key":"BFsrep42601_CR19","doi-asserted-by":"publisher","first-page":"S53","DOI":"10.1038\/modpathol.2010.166","volume":"24","author":"J Rosai","year":"2011","unstructured":"Rosai, J. The origin of neuroendocrine tumors and the neural crest saga. Mod Pathol 24 Suppl 2, S53\u20137 (2011).","journal-title":"Mod Pathol"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep42601","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep42601.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep42601.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T20:14:19Z","timestamp":1671826459000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep42601"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,15]]},"references-count":19,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,3,14]]}},"alternative-id":["BFsrep42601"],"URL":"https:\/\/doi.org\/10.1038\/srep42601","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,15]]},"assertion":[{"value":"17 October 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"42601"}}